Literature DB >> 24210068

Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.

Katarina Nikolic1, Slavica Filipic, Adam Smoliński, Roman Kaliszan, Danica Agbaba.   

Abstract

PURPOSE. Rate of brain penetration (logPS), brain/plasma equilibration rate (logPS-brain), and extent of blood-brain barrier permeation (logBB) of 29 α-adrenergic and imidazoline-receptors ligands were examined in Quantitative-Structure-Property Relationship (QSPR) study. METHODS. Experimentally determined chromatographic retention data (logKw at pH 4.4, slope (S) at pH 4.4, logKw at pH 7.4, slope (S) at pH 7.4, logKw at pH 9.1, and slope (S) at pH 9.1) and capillary electrophoresis migration parameters (μeff at pH 4.4, μeff at pH 7.4, and μeff at pH 9.1), together with calculated molecular descriptors, were used as independent variables in the QSPR study by use of partial least square (PLS) methodology. RESULTS. Predictive potential of the formed QSPR models, QSPR(logPS), QSPR(logPS-brain), QSPR(logBB), was confirmed by cross- and external validation. Hydrophilicity (Hy) and H-indices (H7m) were selected as significant parameters negatively correlated with both logPS and logPS-brain, while topological polar surface area (TPSA(NO)) was chosen as molecular descriptor negatively correlated with both logPS and logBB. The principal component analysis (PCA) and hierarchical clustering analysis (HCA) were applied to cluster examined drugs based on their chromatographic, electrophoretic and molecular properties. Significant positive correlations were obtained between the slope (S) at pH 7.4 and logBB in A/B cluster and between the logKw at pH 9.1 and logPS in C/D cluster. CONCLUSIONS. Results of the QSPR, clustering and correlation studies could be used as novel tool for evaluation of blood-brain barrier permeation of related α-adrenergic/imidazoline receptor ligands.This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.PURPOSE. Rate of brain penetration (logPS), brain/plasma equilibration rate (logPS-brain), and extent of blood-brain barrier permeation (logBB) of 29 α-adrenergic and imidazoline-receptors ligands were examined in Quantitative-Structure-Property Relationship (QSPR) study. METHODS. Experimentally determined chromatographic retention data (logKw at pH 4.4, slope (S) at pH 4.4, logKw at pH 7.4, slope (S) at pH 7.4, logKw at pH 9.1, and slope (S) at pH 9.1) and capillary electrophoresis migration parameters (μeff at pH 4.4, μeff at pH 7.4, and μeff at pH 9.1), together with calculated molecular descriptors, were used as independent variables in the QSPR study by use of partial least square (PLS) methodology. RESULTS. Predictive potential of the formed QSPR models, QSPR(logPS), QSPR(logPS-brain), QSPR(logBB), was confirmed by cross- and external validation. Hydrophilicity (Hy) and H-indices (H7m) were selected as significant parameters negatively correlated with both logPS and logPS-brain, while topological polar surface area (TPSA(NO)) was chosen as molecular descriptor negatively correlated with both logPS and logBB. The principal component analysis (PCA) and hierarchical clustering analysis (HCA) were applied to cluster examined drugs based on their chromatographic, electrophoretic and molecular properties. Significant positive correlations were obtained between the slope (S) at pH 7.4 and logBB in A/B cluster and between the logKw at pH 9.1 and logPS in C/D cluster. CONCLUSIONS. Results of the QSPR, clustering and correlation studies could be used as novel tool for evaluation of blood-brain barrier permeation of related α-adrenergic/imidazoline receptor ligands. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24210068     DOI: 10.18433/j3jk5p

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  7 in total

1.  ADME properties evaluation in drug discovery: in silico prediction of blood-brain partitioning.

Authors:  Lu Zhu; Junnan Zhao; Yanmin Zhang; Weineng Zhou; Linfeng Yin; Yuchen Wang; Yuanrong Fan; Yadong Chen; Haichun Liu
Journal:  Mol Divers       Date:  2018-08-06       Impact factor: 2.943

Review 2.  Is Tamsulosin Linked to Dementia in the Elderly?

Authors:  Jason K Frankel; Yinghui Duan; Peter C Albertsen
Journal:  Curr Urol Rep       Date:  2018-07-03       Impact factor: 3.092

3.  Implementing Silica Nanoparticles in the Study of the Airborne Transmission of SARS-CoV-2.

Authors:  Robert Hildebrandt; Krystian Skubacz; Izabela Chmielewska; Zdzisław Dyduch; Aleksandra Zgórska; Adam Smoliński
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

4.  Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.

Authors:  Małgorzata Girek; Karol Kłosiński; Bartłomiej Grobelski; Stefania Pizzimenti; Marie Angele Cucci; Martina Daga; Giuseppina Barrera; Zbigniew Pasieka; Kamila Czarnecka; Paweł Szymański
Journal:  Mol Cell Biochem       Date:  2019-07-16       Impact factor: 3.396

5.  Towards Deep Neural Network Models for the Prediction of the Blood-Brain Barrier Permeability for Diverse Organic Compounds.

Authors:  Eugene V Radchenko; Alina S Dyabina; Vladimir A Palyulin
Journal:  Molecules       Date:  2020-12-13       Impact factor: 4.411

Review 6.  Biological Membrane-Penetrating Peptides: Computational Prediction and Applications.

Authors:  Ewerton Cristhian Lima de Oliveira; Kauê Santana da Costa; Paulo Sérgio Taube; Anderson H Lima; Claudomiro de Souza de Sales Junior
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

7.  Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity.

Authors:  Mariana Maier Gaelzer; Bárbara Paranhos Coelho; Alice Hoffmann de Quadros; Juliana Bender Hoppe; Silvia Resende Terra; Maria Cristina Barea Guerra; Vanina Usach; Fátima Costa Rodrigues Guma; Carlos Alberto Saraiva Gonçalves; Patrícia Setton-Avruj; Ana Maria Oliveira Battastini; Christianne Gazzana Salbego
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.